MyEClinic
MyEClinic
Health Dictionary Find a Doctor

MACOP-B regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:MACOP-B Regimen; Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen

Overview

Overview

MACOP-B regimen refers to a regimen consisting of methotrexate, doxorubicin (adriamycin), cyclophosphamide, vincristine (Oncovin) and prednisone, bleomycin used to treat aggressive forms of non-Hodgkin’s lymphoma.[1][2]

Regimen

Regimen

MMethotrexate

ADoxorubicin (Adriamycin)

CCyclophosphamide

OVincristine (Oncovin)

PPrednisone

BBleomycin

Indications

Indications

References

References

  1. ↑ 1.0 1.1 De Sanctis V, Finolezzi E, Osti MF, Grapulin L, Alfò M, Pescarmona E; et al. (2008). “MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma”. Int J Radiat Oncol Biol Phys. 72 (4): 1154–60. doi:10.1016/j.ijrobp.2008.02.036. PMID 18472357.
  2. ↑ “NCI Thesaurus”.
  3. ↑ “NCI Thesaurus”.

Looking for the patient version?

Back to the patient-friendly article

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH